Novus and resilient biotics join forces

Boosting swine health through smart nutrition

Novus International, Inc., a global leader in intelligent nutrition, has partnered with Resilient Biotics, a biotechnology company specializing in microbiome-based strategies, to co-develop a groundbreaking feed solution aimed at improving immune health and mitigating respiratory challenges in pigs.

“Respiratory challenges like porcine reproductive and respiratory syndrome (PRRS), porcine respiratory disease complex (PRDC), and others create a strain on pig health and cost the industry billions each year in production loss. The industry eagerly wants to find unique ways to optimize pig health and impact the risk of these challenges,” said Gaurav Shah, NOVUS Associate Director of Innovation and Business Development. “NOVUS and Resilient Biotics are working to address these challenges in a way that hasn’t been done before. We’re very excited to work with Resilient Biotics to develop a new kind of feed solution that can make a huge impact on the swine industry.”

Based in North Carolina, Resilient Biotics leverages its proprietary microbiome discovery platform and extensive databases on swine microbial strains to develop precision solutions. “Resilient Biotics is excited to partner with NOVUS to bring novel microbial solutions to the market. The joint development effort will leverage Resilient Biotics’ deep knowledge of the swine respiratory microbiome and proven discovery platform to identify

proprietary swine microbials that improve host health and boost defense against respiratory pathogens,” said Chris Belnap, Resilient Biotics CEO and co-founder.

The joint project focuses on creating a feed product that offers consistent and measurable benefits to swine health. The product development process, expected to span three years, will include rigorous testing to ensure its efficacy and reliability.

This initiative aligns with Novus’ broader commitment to innovation in animal agriculture. In addition to this collaboration, Novus has partnered with Ginkgo Bioworks to create a new enzyme solution and acquired BioResource International, Inc. (BRI) to enhance its CIBENZA® Enzyme Feed Additive line.

“The partnership with Resilient Biotics is another example of how important innovation and developing new technologies is to NOVUS and how – through science – we’re providing solutions that make the animal agriculture industry more sustainable,” said NOVUS President and CEO Dan Meagher. “Every year meat, milk, and egg producers are expected to do more with less. We’re here to help our customers meet their goals through intelligent nutrition built on advanced technology.”

Novus specializes in solutions that enhance animal nutrition and performance, offering products such as trace minerals, nutritional enzymes, and gut health enhancers. Resilient Biotics focuses on improving livestock respiratory health through advanced microbial discovery and development technologies.